Showing results (71-80 of 142) with videos related to

Sort By:
Pageof 15
Hematological Oncology|March 23, 2022
Correspondence in reference to the previously published manuscript: Reduction of cycles of bendamustine plus rituximab therapy in the cases with good response for indolent B-cell lymphomasFrancesco Autore, Alberto Fresa, Idanna Innocenti, et al.
Thrombosis Research|October 5, 2013
Infections increase the risk of central venous catheter-related thrombosis in adult acute myeloid leukemiaMaria Ilaria Del Principe, Francesco Buccisano, Luca Maurillo, et al.
Haematologica|November 14, 2015
Clinical significance of bax/bcl-2 ratio in chronic lymphocytic leukemiaMaria Ilaria Del Principe, Michele Dal Bo, Tamara Bittolo, et al.
American Journal of Hematology|July 19, 2016
Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective surveyEnrico Maria Trecarichi, Livio Pagano, Bruno Martino, et al.
Thrombosis Research|February 22, 2024
The ISTH DIC-score predicts early mortality in patients with non-promyelocitic acute myeloid leukemiaGiovangiacinto Paterno, Raffaele Palmieri, Cristiano Tesei, et al.
Leukemia|June 22, 2023
MCL1 regulates AML cells metabolism via direct interaction with HK2. Metabolic signature at onset predicts overall survival in AMLs' patientsGianfranco Catalano, Alessandra Zaza, Cristina Banella, et al.
Journal of Clinical Medicine|April 12, 2022
In BCR-ABL1 Positive B-Cell Acute Lymphoblastic Leukemia, Steroid Therapy Induces HypofibrinogenemiaElisa Buzzatti, Fabio Forghieri, Giovangiacinto Paterno, et al.
Expert Review of Hematology|December 30, 2017
SEIFEM 2017: from real life to an agreement on the use of granulocyte transfusions and colony-stimulating factors for prophylaxis and treatment of infectious complications in patients with hematologic malignant disordersAlessandro Busca, Simone Cesaro, Luciana Teofili, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 9, 2008
Toward optimization of postremission therapy for residual disease-positive patients with acute myeloid leukemiaLuca Maurillo, Francesco Buccisano, Maria Ilaria Del Principe, et al.
American Journal of Hematology|November 8, 2014
Minimal residual disease as biomarker for optimal biologic dosing of ARA-C in patients with acute myeloid leukemiaLuca Maurillo, Francesco Buccisano, Alfonso Piciocchi, et al.
Pageof 15